Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective

被引：0
|
作者：
Barbara Fischer
Andreas Serra
Harry Telser
机构：
[1] Polynomics,Department of Internal Medicine and Nephrology
[2] Klinik Hirslanden,Center for Health, Policy and Economics
[3] University of Lucerne,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Chronic kidney disease; Hyperkalemia; Patiromer; Potassium binder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2717 / 2730
页数：13
相关论文
共 50 条
  • [1] Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin-Angiotensin-Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective
    Fischer, Barbara
    Serra, Andreas
    Telser, Harry
    ADVANCES IN THERAPY, 2022, 39 (06) : 2717 - 2730
  • [2] Cost-Effectiveness Analysis of Patiromer in Combination with Renin–Angiotensin–Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden
    Julia Widén
    Magnus Ivarsson
    Lovisa Schalin
    Polina Vrouchou
    Matthias Schwenkglenks
    Olof Heimbürger
    Zanfina Ademi
    C. Simone Sutherland
    PharmacoEconomics, 2020, 38 : 747 - 764
  • [3] Cost-Effectiveness Analysis of Patiromer in Combination with Renin-Angiotensin-Aldosterone System Inhibitors for Chronic Kidney Disease in Sweden
    Widen, Julia
    Ivarsson, Magnus
    Schalin, Lovisa
    Vrouchou, Polina
    Schwenkglenks, Matthias
    Heimburger, Olof
    Ademi, Zanfina
    Sutherland, C. Simone
    PHARMACOECONOMICS, 2020, 38 (07) : 747 - 764
  • [4] Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors
    Weir, Matthew R.
    Bakris, George L.
    Gross, Coleman
    Mayo, Martha R.
    Garza, Dahlia
    Stasiv, Yuri
    Yuan, Jinwei
    Berman, Lance
    Williams, Gordon H.
    KIDNEY INTERNATIONAL, 2016, 90 (03) : 696 - 704
  • [5] Cost Consequence Analysis of the Management of Hyperkalemia by Patiromer and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Chronic Kidney Disease Patients in Saudi Arabia
    Shaheen, Faissal
    Meunier, Aurelie
    Altowaijri, Abdulaziz
    Faadhel, Talal
    Al-Abdulkarim, Hana
    AlGabash, Adnan
    Floros, Lefteris
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2022, 33 : 39 - 52
  • [6] Management of Hyperkalemia in Patients with Chronic Kidney Disease Using Renin Angiotensin Aldosterone System Inhibitors
    Michelle A. Fravel
    Calvin J. Meaney
    Lama Noureddine
    Current Hypertension Reports, 2023, 25 : 395 - 404
  • [7] Management of Hyperkalemia in Patients with Chronic Kidney Disease Using Renin Angiotensin Aldosterone System Inhibitors
    Fravel, Michelle A.
    Meaney, Calvin J.
    Noureddine, Lama
    CURRENT HYPERTENSION REPORTS, 2023, 25 (11) : 395 - 404
  • [8] 1-YEAR SAFETY AND EFFICACY OF PATIROMER FOR HYPERKALEMIA IN HEART FAILURE PATIENTS WITH CHRONIC KIDNEY DISEASE ON RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS
    Pitt, Bertram
    Bushinsky, David
    Garza, Dahlia
    Stasiv, Yuri
    Du Mond, Charles
    Berman, Lance
    Bakris, George
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A855 - A855
  • [9] A cost-effectiveness analysis of patiromer for the treatment of hyperkalemia in chronic kidney disease patients with and without heart failure in Spain
    Ramon Gonzalez-Juanatey, Jose
    Gonzalez-Franco, Alvaro
    de Sequera, Patricia
    Valls, Marta
    Ramirez de Arellano, Antonio
    Pomares, Elisenda
    Nieves, Diana
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 640 - 649
  • [10] Management of Hyperkalemia in Renin-Angiotensin-Aldosterone System Inhibitor: Strategies to Maintain Chronic Kidney Disease Patients with Type II Diabetes on Therapy
    Mahmud, Humaira A.
    Palmer, Biff F.
    CARDIORENAL MEDICINE, 2024, 14 (01) : 191 - 201
12345